About

Gonçalo Rebelo de Andrade is Chief of Business Operations at Nanoform Finland. Before that he was Director at Hovione Technology. He holds a PhD in Biochemistry from Ludwig Maximillian University in Munich and earned his Lisbon MBA course degree at Nova/Catolica Business School. He joined the Hovione group in 2013 as a business development manager for inhalation drug development services and for the dry powder inhalers within Hovione’s portfolio, which he led until March 2016. Dr Andrade has >15 years’ experience in the life sciences sector in the US, Germany and Portugal where he worked for both large companies and startups and a clear vision on the hurdles connected to the drug development of inhaled drugs.

Contributions

PULMONARY

SCALING-UP FOR HIGH DOSE DELIVERY TO THE LUNGS

João Ventura Fernandes, Gonçalo Rebelo de Andrade and Peter Villax describe the scaling up of the currently marketed TwinCaps® inhaler into the new TwinMax™ design for high-dose delivery of challenging drug-alone formulations in single to short-term treatments and emergency situations.

More contributions

PULMONARY

SCALE-UP & QBD APPROACHES FOR SPRAY-DRIED INHALATION FORMULATIONS

Eunice Costa, Filipe Neves, Gonçalo Andrade and Conrad Winters describe the strong position of inhalable products in preclinical and clinical pipelines and make the case for formulation-based approaches to enable and enhance pulmonary product development. Spray-drying technology in particular is highlighted as a highly favourable, scalable manufacturing technique for inhalable composite particles.